News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meridian Co. Ltd. (MRDAF) Expands in the Scandinavian Market


3/19/2009 10:56:44 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 19, 2009) - Meridian Co., Ltd. (OTCBB: MRDAF), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that it has signed an exclusive contract with Sweden based Aesthetic DERMA PRO ("Aesthetic") for the marketing and sales of Meridian's LAPEX 2000 BCS in Scandinavian countries.

The contract outlines that Aesthetic has been granted a one year exclusive license to market the LAPEX 2000 BCS series in Sweden, Norway, Denmark and Finland. Aesthetic is engaged in the business of the sale and distribution of specialty medical devices and related products in these countries.

Meridian signed a similar contract for 2 years with Estetik Media International for sales of the product in Romania last September.

"Despite the global economic recession, LAPEX 2000 BCS still attracts great interest from European countries," says Hyeon Seung Myeong, president and CEO of Meridian.

"It has been just over two years since the LAPEX 2000 BCS was first introduced to the European markets, and we have secured several solid distribution partners in most of Northern and Middle Europe."

Meridian looks forward to finalizing distribution contracts with Southern European countries before Quarter 3 of 2009.

About Merdian Co., Ltd.

Meridian is a leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 5 patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe. Meridian continues to successfully market its superior product line to a growing number of clients worldwide.

Safe Harbor Statement

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Forward looking statements in this press release include that Meridian expects to sign distributorship contracts with Southern European countries before the first half of 2009.

Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors which could prevent this statement from coming to fruition include that we are not able to agree on terms with any distributor in Southern Europe. Other risk factors are set out in our periodic reports on forms 20-F filed on Edgar. This document is not intended to be and is not an advertisement for any securities of the Company.


Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: www.MeridianMedical.ca


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES